These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35900472)

  • 1. Proliferation and Self-Renewal Are Differentially Sensitive to NRASG12V Oncogene Levels in an Acute Myeloid Leukemia Cell Line.
    Kurata M; Antony ML; Noble-Orcutt KE; Rathe SK; Lee Y; Furuno H; Ishibashi S; Ikeda M; Yamamoto K; Kitagawa M; Largaespada DA; Sachs Z
    Mol Cancer Res; 2022 Nov; 20(11):1646-1658. PubMed ID: 35900472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia.
    Sachs Z; LaRue RS; Nguyen HT; Sachs K; Noble KE; Mohd Hassan NA; Diaz-Flores E; Rathe SK; Sarver AL; Bendall SC; Ha NA; Diers MD; Nolan GP; Shannon KM; Largaespada DA
    Blood; 2014 Nov; 124(22):3274-83. PubMed ID: 25316678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.
    Kim WI; Matise I; Diers MD; Largaespada DA
    Blood; 2009 Jan; 113(5):1086-96. PubMed ID: 18952898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.
    Xue L; Pulikkan JA; Valk PJ; Castilla LH
    Blood; 2014 Jul; 124(3):426-36. PubMed ID: 24894773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.
    Brendel C; Teichler S; Millahn A; Stiewe T; Krause M; Stabla K; Ross P; Huynh M; Illmer T; Mernberger M; Barckhausen C; Neubauer A
    PLoS One; 2015; 10(4):e0123181. PubMed ID: 25901794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RALB provides critical survival signals downstream of Ras in acute myeloid leukemia.
    Eckfeldt CE; Pomeroy EJ; Lee RD; Hazen KS; Lee LA; Moriarity BS; Largaespada DA
    Oncotarget; 2016 Oct; 7(40):65147-65156. PubMed ID: 27556501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical efficacy of MEK inhibition in Nras-mutant AML.
    Burgess MR; Hwang E; Firestone AJ; Huang T; Xu J; Zuber J; Bohin N; Wen T; Kogan SC; Haigis KM; Sampath D; Lowe S; Shannon K; Li Q
    Blood; 2014 Dec; 124(26):3947-55. PubMed ID: 25361812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-leukemic effects of simvastatin on NRAS
    Jang J; Lee J; Jang JH; Jung CW; Park S
    Mol Biol Rep; 2019 Dec; 46(6):5859-5866. PubMed ID: 31452046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
    Zhang J; Kong G; Rajagopalan A; Lu L; Song J; Hussaini M; Zhang X; Ranheim EA; Liu Y; Wang J; Gao X; Chang YI; Johnson KD; Zhou Y; Yang D; Bhatnagar B; Lucas DM; Bresnick EH; Zhong X; Padron E; Zhang J
    Blood; 2017 Jan; 129(3):358-370. PubMed ID: 27815262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemias.
    Kvinlaug BT; Chan WI; Bullinger L; Ramaswami M; Sears C; Foster D; Lazic SE; Okabe R; Benner A; Lee BH; De Silva I; Valk PJ; Delwel R; Armstrong SA; Döhner H; Gilliland DG; Huntly BJ
    Cancer Res; 2011 Jun; 71(12):4117-29. PubMed ID: 21505102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state.
    Antony ML; Chang D; Noble-Orcutt KE; Kay A; Jensen JL; Mohei H; Myers CL; Sachs K; Sachs Z
    Leuk Lymphoma; 2023; 64(7):1262-1274. PubMed ID: 37161853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
    Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A
    J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic viral integration Site-1 oncogene promotes NRAS pathway through epigenetic silencing of microRNA-124 in acute myeloid leukemia.
    Lang W; Han X; Cai J; Chen F; Xu L; Zhong H; Zhong J
    Cell Signal; 2022 Nov; 99():110402. PubMed ID: 35835333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.
    Heuser M; Sly LM; Argiropoulos B; Kuchenbauer F; Lai C; Weng A; Leung M; Lin G; Brookes C; Fung S; Valk PJ; Delwel R; Löwenberg B; Krystal G; Humphries RK
    Blood; 2009 Nov; 114(19):3983-93. PubMed ID: 19667399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice.
    Parikh C; Subrahmanyam R; Ren R
    Blood; 2006 Oct; 108(7):2349-57. PubMed ID: 16763213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.
    Shi J; Wang E; Zuber J; Rappaport A; Taylor M; Johns C; Lowe SW; Vakoc CR
    Oncogene; 2013 Feb; 32(7):930-8. PubMed ID: 22469984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
    Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
    Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
    Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
    Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.